Home
>
National Drug Code (NDC)
>
Erythromycin
Erythromycin - 55045-1350-9 - (Erythromycin)
Drug Information of Erythromycin
| Product NDC: | 55045-1350 |
| Proprietary Name: | Erythromycin |
| Non Proprietary Name: | Erythromycin |
| Active Ingredient(s): | 5 mg/g & nbsp; Erythromycin |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Erythromycin
| Product NDC: | 55045-1350 |
| Labeler Name: | Dispensing Solutions, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064030 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19960718 |
Package Information of Erythromycin
| Package NDC: | 55045-1350-9 |
| Package Description: | 1 TUBE in 1 CARTON (55045-1350-9) > 3.5 g in 1 TUBE |
NDC Information of Erythromycin
| NDC Code | 55045-1350-9 |
| Proprietary Name | Erythromycin |
| Package Description | 1 TUBE in 1 CARTON (55045-1350-9) > 3.5 g in 1 TUBE |
| Product NDC | 55045-1350 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin |
| Dosage Form Name | OINTMENT |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19960718 |
| Marketing Category Name | ANDA |
| Labeler Name | Dispensing Solutions, Inc. |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
